Wagenbauer, K.F.* ; Pham, N.* ; Gottschlich, A.* ; Kick, B.* ; Kozina, V.* ; Frank, C.* ; Trninic, D.* ; Stömmer, P.* ; Grünmeier, R.* ; Carlini, E.* ; Tsiverioti, C.A.* ; Kobold, S. ; Funke, J.J.* ; Dietz, H.*
Programmable multispecific DNA-origami-based T-cell engagers.
Nat. Nanotechnol. 18, 1319-1326 (2023)
Multispecific antibodies have emerged as versatile therapeutic agents, and therefore, approaches to optimize and streamline their design and assembly are needed. Here we report on the modular and programmable assembly of IgG antibodies, F(ab) and scFv fragments on DNA origami nanocarriers. We screened 105 distinct quadruplet antibody variants in vitro for the ability to activate T cells in the presence of target cells. T-cell engagers were identified, which in vitro showed the specific and efficient T-cell-mediated lysis of five distinct target cell lines. We used these T-cell engagers to target and lyse tumour cells in vivo in a xenograft mouse tumour model. Our approach enables the rapid generation, screening and testing of bi- and multispecific antibodies to facilitate preclinical pharmaceutical development from in vitro discovery to in vivo proof of concept.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Folding Dna; Nanostructures; Antibodies; Nanorobot
Keywords plus
Language
english
Publication Year
2023
Prepublished in Year
0
HGF-reported in Year
2023
ISSN (print) / ISBN
1748-3387
e-ISSN
1748-3395
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 18,
Issue: 11,
Pages: 1319-1326
Article Number: ,
Supplement: ,
Series
Publisher
Nature Publishing Group
Publishing Place
London
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Unit for Clinical Pharmacology (KKG-EKLiP)
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-522100-001
Grants
Deutsche Forschungsgemeinschaft (DFG)
Medical Valley Award
GO-Bio initial award (Federal Ministry of Education and Research (BMBF) of Germany) a
ForTra gGmbH fuer Forschungstransfer der Else Kroener-Fresenius Stiftung
Max Planck School Matter to Life - Federal Ministry of Education and Research (BMBF) of Germany
Max Planck Society
Bavarian Academy of Science
international doctoral program the Foerderprogramm fuer Forschung und Lehre der Medizinischen Fakultaet der LMU
DFG
Elite Network of Bavaria
Melanoma Research Alliance
Horizon 2020 programme of the European Union
Else Kroener-Fresenius-Stiftung
German Cancer Aid
Ernst Jung Stiftung
European Research Council Consolidator Grant
Institutional Strategy LMUexcellent of LMU Munich
Bundesministerium fuer Bildung und Forschung
European Research Council
Fritz-Bender Foundation
Deutsche Jose Carreras Leukaemie Stiftung
Hector Foundation
Wilhelm-Sander Stiftung
Copyright
Erfassungsdatum
2023-10-06